Today

Agents

Chat

Arena

Discover

More

App

Quince Therapeutics President Charles Ryan to exit Sept. 8 - QNCX News | Rallies

Quince Therapeutics President Charles Ryan to exit Sept. 8

QNCX•2026-08-27

President departure date set

Quince Therapeutics President Charles Ryan will leave the company on Sept. 8, 2026.
The decision was reached on Aug. 23, 2026.

Related News

RenaissanceRe EVP, Chief Portfolio Officer Curtis Ross sells 377 common shares for $126,295

RNR•2026-08-27

Hinge Health director Elliott Robinson reports disposal of shares worth $30.71 million

HNGE•2026-08-27

Carpenter Technology CEO Tony R. Thene sells $42.98 million in common shares

CRS•2026-08-27

Sources

S

Quince Therapeutics President Charles Ryan to exit Sept. 8

Sec

Gen Digital director Ondrej Vlcek sells 152,358 common shares worth $4.42 million

GEN•2026-08-27

LeMaitre Vascular CFO joins Wells Fargo healthcare conference fireside chat

LMAT•2026-08-27